{"id":28810,"date":"2023-04-27T15:07:41","date_gmt":"2023-04-27T19:07:41","guid":{"rendered":"https:\/\/www.cancerresearch.org\/?post_type=cri_events&p=28810"},"modified":"2023-05-03T11:46:35","modified_gmt":"2023-05-03T15:46:35","slug":"cri-at-asco-gynecologic","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/cri-at-asco-gynecologic","title":{"rendered":"CRI at ASCO – Gynecologic Cancer"},"content":{"rendered":"\n

CRI at ASCO – Gynecologic Cancer<\/p>\n\n\n\n

Authors<\/h4>\n\n\n\n

person<\/p>\n\n\n\n

Helen Mackay<\/h5>\n\n\n\n

Odette Cancer Centre, Sunnybrook Health Sciences Centreinfo_outline<\/p>\n\n\n\n

Helen Mackay, Anna Tinker, Brad Nelson, Dmitriy Zamarin, Kunle Odunsi, Stephanie Lheureux, Susan Ellard, Alannah Smrke, Pierre-Olivier Gaudreau, Tess Faulkner, Ana Saez-Ibanez, Dongsheng Tu, Janet Dancey<\/p>\n\n\n\n

Organizations<\/h6>\n\n\n\n

Odette Cancer Centre, Sunnybrook Health Sciences Centre, BC Cancer – Vancouver, British Columbia Cancer Agency, Memorial Sloan Kettering Cancer Center, University of Chicago, Princess Margaret – University Health Network, British Columbia Cancer Agency- Center for the Southern Interior, BC Cancer, NCIC Clinical Trials Group Queen’s University, Canadian Cancer Trials Group, Cancer Research Institute, Canadian Cancer Trials Group, Queen’s UniversityAbstract Disclosures<\/a><\/p>\n\n\n\n

This material on this page is \u00a92023 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact\u00a0licensing@asco.org<\/a><\/p>\n\n\n\n

Details
First Author<\/p>\n\n\n\n

Helen Mackay
Meeting<\/p>\n\n\n\n

2023 ASCO Annual Meeting
Session Type<\/p>\n\n\n\n

Poster Session
Session Title<\/p>\n\n\n\n

Gynecologic Cancer
Track<\/p>\n\n\n\n

Gynecologic Cancer
Sub Track<\/p>\n\n\n\n

Ovarian Cancer
Clinical Trial Registration Number<\/p>\n\n\n\n

NCT04918186<\/p>\n\n\n\n

Abstract #<\/p>\n\n\n\n

TPS5617<\/p>\n\n\n\n

Poster Bd #<\/p>\n\n\n\n

309b<\/p>\n","protected":false},"excerpt":{"rendered":"

CRI at ASCO – Gynecologic Cancer Authors person Helen Mackay Odette Cancer Centre, Sunnybrook Health Sciences Centreinfo_outline Helen Mackay, Anna Tinker, Brad Nelson, Dmitriy Zamarin, Kunle Odunsi, Stephanie Lheureux, Susan Ellard, Alannah […]<\/p>\n","protected":false},"featured_media":28811,"template":"","events_categories":[199],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-28810","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-conferences"],"acf":[],"yoast_head":"\nCRI at ASCO - Gynecologic Cancer - Cancer Research Institute<\/title>\n<meta name=\"description\" content=\"CRI at ASCO - Gynecologic Cancer. An immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CRI at ASCO - Gynecologic Cancer - Cancer Research Institute\" \/>\n<meta property=\"og:description\" content=\"CRI at ASCO - Gynecologic Cancer. An immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-03T15:46:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/04\/ASCO.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2500\" \/>\n\t<meta property=\"og:image:height\" content=\"1667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic\",\"name\":\"CRI at ASCO - Gynecologic Cancer - Cancer Research Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/04\/ASCO.jpg\",\"datePublished\":\"2023-04-27T19:07:41+00:00\",\"dateModified\":\"2023-05-03T15:46:35+00:00\",\"description\":\"CRI at ASCO - Gynecologic Cancer. An immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC).\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/04\/ASCO.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/04\/ASCO.jpg\",\"width\":2500,\"height\":1667,\"caption\":\"ASCO Conference\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CRI at ASCO – Gynecologic Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CRI at ASCO - Gynecologic Cancer - Cancer Research Institute","description":"CRI at ASCO - Gynecologic Cancer. An immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic","og_locale":"es_ES","og_type":"article","og_title":"CRI at ASCO - Gynecologic Cancer - Cancer Research Institute","og_description":"CRI at ASCO - Gynecologic Cancer. An immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC).","og_url":"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic","og_site_name":"Cancer Research Institute","article_modified_time":"2023-05-03T15:46:35+00:00","og_image":[{"width":2500,"height":1667,"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/04\/ASCO.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic","url":"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic","name":"CRI at ASCO - Gynecologic Cancer - Cancer Research Institute","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/04\/ASCO.jpg","datePublished":"2023-04-27T19:07:41+00:00","dateModified":"2023-05-03T15:46:35+00:00","description":"CRI at ASCO - Gynecologic Cancer. An immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC).","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/04\/ASCO.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2023\/04\/ASCO.jpg","width":2500,"height":1667,"caption":"ASCO Conference"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/cri-at-asco-gynecologic#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"CRI at ASCO – Gynecologic Cancer"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/28810","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/28811"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=28810"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=28810"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=28810"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=28810"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=28810"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=28810"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=28810"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}